Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer
Clinical trial NCT00281866 · COMPLETED
Trial details
- NCT number
- NCT00281866
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2006-10-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.